Get startedLog in
    Picture of LongBio Pharma (Suzhou) Co logo

    1779 — LongBio Pharma (Suzhou) Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly Speculative
    All News

    Brief: Longbio Pharma (Suzhou)Says Phase III Trial Of LP-3 For Seasonal Allergic Rhinitis Meets Primary Endpoints

    Picture of LongBio Pharma (Suzhou) Co logoLongBio Pharma (Suzhou) Co
    12/06/2026 02:36
    BRIEF-Longbio Pharma (Suzhou)Says Phase III Trial Of LP-3 For Seasonal Allergic Rhinitis Meets Primary Endpoints
    June 12 (Reuters) - LongBio Pharma (Suzhou) Co Ltd 1779.HK:
    • PHASE III TRIAL OF LP-3 FOR SEASONAL ALLERGIC RHINITIS MEETS PRIMARY ENDPOINTS
    Further company coverage: 1779.HK

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on LongBio Pharma (Suzhou) Co

    See all news